CRBN
Basic information
Region (hg38): 3:3144628-3179727
Previous symbols: [ "MRT2A" ]
Links
Phenotypes
GenCC
Source:
- intellectual disability, autosomal recessive 2 (Limited), mode of inheritance: AR
- autosomal recessive non-syndromic intellectual disability (Supportive), mode of inheritance: AR
- intellectual disability, autosomal recessive 2 (Limited), mode of inheritance: AR
- intellectual disability (Moderate), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Intellectual developmental disorder, autosomal recessive 2 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 10932263; 15557513; 17036314; 17380424 |
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn_genetic_diseases (49 variants)
- not_provided (37 variants)
- not_specified (19 variants)
- Intellectual_disability,_autosomal_recessive_2 (11 variants)
- CRBN-related_disorder (7 variants)
- Multiple_myeloma (1 variants)
- Intellectual_disability (1 variants)
- See_cases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CRBN gene is commonly pathogenic or not. These statistics are base on transcript: NM_000016302.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 13 | 17 | ||||
| missense | 61 | 70 | ||||
| nonsense | 6 | |||||
| start loss | 0 | |||||
| frameshift | 7 | |||||
| splice donor/acceptor (+/-2bp) | 1 | |||||
| Total | 5 | 8 | 64 | 20 | 4 |
Highest pathogenic variant AF is 0.00000993937
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| CRBN | protein_coding | protein_coding | ENST00000231948 | 11 | 30719 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.000289 | 0.999 | 125713 | 0 | 35 | 125748 | 0.000139 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | -0.0404 | 241 | 239 | 1.01 | 0.0000120 | 2914 |
| Missense in Polyphen | 34 | 50.752 | 0.66993 | 616 | ||
| Synonymous | -1.64 | 100 | 81.2 | 1.23 | 0.00000409 | 788 |
| Loss of Function | 3.01 | 11 | 28.3 | 0.389 | 0.00000142 | 324 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000387 | 0.000387 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.0000544 | 0.0000544 |
| Finnish | 0.000277 | 0.000277 |
| European (Non-Finnish) | 0.000132 | 0.000123 |
| Middle Eastern | 0.0000544 | 0.0000544 |
| South Asian | 0.000131 | 0.000131 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Substrate recognition component of a DCX (DDB1-CUL4-X- box) E3 protein ligase complex that mediates the ubiquitination and subsequent proteasomal degradation of target proteins, such as MEIS2. Normal degradation of key regulatory proteins is required for normal limb outgrowth and expression of the fibroblast growth factor FGF8. May play a role in memory and learning by regulating the assembly and neuronal surface expression of large-conductance calcium-activated potassium channels in brain regions involved in memory and learning via its interaction with KCNT1. Binding of pomalidomide and other thalidomide-related drugs changes the substrate specificity of the human protein, leading to decreased degradation of MEIS2 and other target proteins and increased degradation of MYC, IRF4, IKZF1 and IKZF3. {ECO:0000269|PubMed:18414909, ECO:0000269|PubMed:20223979, ECO:0000269|PubMed:24328678, ECO:0000269|PubMed:25043012, ECO:0000269|PubMed:25108355, ECO:0000305}.;
- Disease
- DISEASE: Mental retardation, autosomal recessive 2A (MRT2A) [MIM:607417]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. Non-syndromic mental retardation patients do not manifest other clinical signs. MRT2A patients display mild mental retardation with a standard IQ ranged from 50 to 70. IQ scores are lower in males than females. Developmental milestones are mildly delayed. There are no dysmorphic or autistic features. {ECO:0000269|PubMed:15557513, ECO:0000269|PubMed:28143899}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Intolerance Scores
- loftool
- 0.219
- rvis_EVS
- -0.58
- rvis_percentile_EVS
- 18.59
Haploinsufficiency Scores
- pHI
- 0.195
- hipred
- Y
- hipred_score
- 0.611
- ghis
- 0.592
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.807
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Crbn
- Phenotype
- liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); reproductive system phenotype; homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); growth/size/body region phenotype;
Zebrafish Information Network
- Gene name
- crbn
- Affected structure
- pectoral fin
- Phenotype tag
- abnormal
- Phenotype quality
- malformed
Gene ontology
- Biological process
- protein ubiquitination;negative regulation of protein homooligomerization;negative regulation of ion transmembrane transport;proteasome-mediated ubiquitin-dependent protein catabolic process;positive regulation of protein homodimerization activity
- Cellular component
- nucleus;nucleolus;cytoplasm;membrane;Cul4A-RING E3 ubiquitin ligase complex
- Molecular function
- protein binding;metal ion binding